Worldwide, its prevalence among newborns is 1.14 per 100,000, demonstrating an increasing trend over time, whereas the prevalence in clinically suspected patients reaches 652.11 per 100,000 (Jin et al. 2022 ).
← all excerpts
Metabolic toxicity and neurological dysfunction in methylmalonic acidemia: from mechanisms to therapeutics.
1
—
—